Preoperative serum CA 72.4 as prognostic factor of recurrence and death, especially at TNM stage II, for colorectal cancer

BACKGROUND: Nowadays, evaluation of colorectal cancer prognosis and decision-making for treatment continues to be based primarily on TNM tumour stage. Administration of adjuvant chemotherapy is especially challenging for stage II patients that can have very different disease-related outcomes. Theref...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayude, Daniel, Rodríguez-Berrocal, Francisco Javier, Ayude, José, Blanco-Prieto, Sonia, Vázquez-Iglesias, Lorena, Vázquez-Cedeira, Marta, Páez de la Cadena, María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829802/
https://www.ncbi.nlm.nih.gov/pubmed/24215576
http://dx.doi.org/10.1186/1471-2407-13-543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829802/
https://www.ncbi.nlm.nih.gov/pubmed/24215576
http://dx.doi.org/10.1186/1471-2407-13-543

Ejemplares similares